Compare CVS Health Corp (CVS) vs Enphase Energy Inc (ENPH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Enphase Energy Inc — how do they compare? CVS Health Corp trades at $86.25 (market cap $112.49B), while Enphase Energy Inc trades at $33.24 (market cap $4.43B). The key difference: CVS Health Corp is far larger — about 25.4× Enphase Energy Inc's market cap, and CVS Health Corp pays a 3.02% dividend while Enphase Energy Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Enphase Energy Inc for 72 Days on average.
| CVS | ENPH | |
|---|---|---|
Market Cap | $112.49B | $4.43B |
Volume | 8,467,392 | 3,388,482 |
Sector | Health | Energy |
52-Week High | $110.60 | $72.33 |
52-Week Low | $70.08 | $26.12 |
Typical Hold Time | 83 Days | 72 Days |
Enterprise Value | $174.83B | $4.07B |
Dividend Yield | 3.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
Enphase Energy (ENPH) trades at $32.91, down 2.95% on the day, amid a bearish technical signal and mixed earnings history. The stock shows weakening revenue and net income from 2023 peaks, with 2025 revenue at $1.47B and net income of $172.13M. Recent news highlights volatility in solar stocks due to high borrowing costs, though Enphase advances with IQ Meter Collar approvals and solid-state transformer development for AI data centers.
Outlook is cautious; while analyst consensus targets $42.90 (30% upside), recent earnings misses and bearish technicals suggest near-term pressure. Risks include solar industry headwinds and execution challenges, but long-term growth potential exists in energy technology expansion. Investors should weigh valuation metrics like P/E of 33.17 against competitive and macroeconomic risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Enphase Energy Inc
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →
